Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.619
+0.009 (0.53%)
Aug 10, 2026, 11:39 AM EDT - Market open
Imunon Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
6.80M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 500.00K | - | - |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | 500.00K | - | - |
| Dec 31, 2019 | 500.00K | - | - |
| Dec 31, 2018 | 500.00K | - | - |
| Dec 31, 2017 | 500.00K | - | - |
| Dec 31, 2016 | 500.00K | - | - |
| Dec 31, 2015 | 500.00K | - | - |
| Dec 31, 2014 | 500.00K | - | - |
| Dec 31, 2013 | 500.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | 2.00M | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | 2.50M | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
IMNN News
- 11 days ago - Imunon provides update on OVATION 3 trial of IMNN-001 - TheFly
- 11 days ago - IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewsWire
- 18 days ago - IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development - GlobeNewsWire
- 20 days ago - Imunon announces new preliminary data from IMNN-001 trial - TheFly
- 20 days ago - IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer - GlobeNewsWire
- 5 weeks ago - Imunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed - TheFly
- 6 weeks ago - Imunon Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 6 weeks ago - Imunon Slides: Life Sciences Virtual Investor Forum - Filings